Regardless, the finding that CD4+ CTLs are predisposed to invoke B cells and mediate humoral immunity through CXCL13 expression emphasizes their central role in tumor immunity in addition to their CD8+ CTL counterparts. This evidence concerns the gene CD4 and neoplasm.